Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
8.31M
-
Shares change
-
+8.31M
-
Total reported value, excl. options
-
$162M
-
Value change
-
+$162M
-
Number of buys
-
28
-
Price
-
$19.73
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2018
28 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q2 2018.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.31M shares
of 92.4M outstanding shares and own 8.99% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.41M shares), ORBIMED ADVISORS LLC (1.48M shares), FMR LLC (1.1M shares), Fosun International Ltd (796K shares), FIL Ltd (418K shares), GILDER GAGNON HOWE & CO LLC (149K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (147K shares), CONNING INC. (131K shares), SPHERA FUNDS MANAGEMENT LTD. (126K shares), and Monashee Investment Management LLC (100K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.